Off-on fluorescence monitoring of intracellular Ag+ in single living cells using an Ag+-responsive probe

0D/2D heteronanostructure-integrated bimetallic CoCu-ZIF nanosheets and MXene-derived carbon dots for impedimetric cytosensing of melanoma B16-F10 cells

A novel heterogeneous architecture has been constructed integrating two-dimensional (2D) bimetallic CoCu-zeolite imidazole framework (CoCu-ZIF) and zero-dimensional (0D) Ti₃C₂T_x MXene-derived carbon dots (CDs) (represented by CoCu-ZIF@CDs). The prepared CoCu-ZIF@CDs were further explored as sensitive layer for anchoring B16-F10 cell-targeted aptamer strands and detecting B16-F10 cells from the biological environment. Basic characterization showed that CDs were homogeneously embedded within CoCu-ZIF NSs owing to their π-π stacking interaction, leading to outstanding fluorescence performance of the 0D/2D CoCu-ZIF@CD nanohybrid. As such, the CoCu-ZIF@CD-based cytosensor was applied to detect living B16-F10 cells through electrochemical techniques and cell imaging. Compared with CoCu-ZIF- and CD-based cytosensors, the constructed CoCu-ZIF@CD-based one showed superior sensing performance, with an extremely low limit of detection (LOD) of 33 cells∙mL^-1 and a wide range of suspension concentration of 1 × 10²-1 × 10⁵ cells∙mL^-1 B16-F10 cells. The developed cytosensor also demonstrated excellent detection performance, including cell imaging properties, good selectivity, high stability, and good reproducibility. By anchoring other probe molecules, the constructed CoCu-ZIF@CD-based biosensor can be extensively explored for early diagnosis of other analytes, thereby widening the applications of porous organic frameworks in biosensing and biomedical fields. A novel sensing system for melanoma B16-F10 cells based on a novel CoCu-ZIF@CD nanohybrid has been developed. The CoCu-ZIF@CDs-based cytosensor displayed an extremely low limit of detection (LOD) of 33 cells∙mL^-1 within the wide range of B16-F10 cell concentration from 1 × 10² to 1 × 10⁵ cells∙mL^-1, accompanying with cell imaging properties, good selectivity, high stability, and well reproducibility.

Interaction of 2,6,7-Trihydroxy-Xanthene-3-Ones with Iron and Copper, and Biological Effect of the Most Active Derivative on Breast Cancer Cells and Erythrocytes

Metal chelators can be potentially employed in the treatment of various diseases, ranging from metal overload to neoplastic conditions. Some xanthene derivatives were previously reported to complex metals. Thus, in a search for a novel iron or copper chelator, a series of 9-(substituted phenyl)-2,6,7-trihydroxy-xanthene-3-ones was tested using a competitive spectrophotometric approach. The most promising compound was evaluated in biological models (breast adenocarcinoma cell lines and erythrocytes). In general, substitution of the benzene ring in position 9 had a relatively low effect on the chelation. Only the trifluoromethyl substitution resulted in stronger chelation, probably via a positive effect on solvation. All compounds chelated iron, but their copper-chelating effect was only minimal, since it was no longer observed under highly competitive conditions. Interestingly, all compounds reduced both iron and copper. Additional experiments showed that the trifluoromethyl derivative protected erythrocytes and even cancer cells against excess copper. In summary, the tested compounds are iron chelators, which are also capable of reducing iron/copper, but the copper-reducing effect is not associated with increased copper toxicity.